Biomarker for Spinal Muscular Atrophy: Expression of SMN in Peripheral Blood of SMA Patients and Healthy Controls.

Spinal muscular atrophy is caused by a functional deletion of SMN1 on Chromosome 5, which leads to a progressive loss of motor function in affected patients. SMA patients have at least one copy of a similar gene, SMN2, which produces functional SMN protein, although in reduced quantities. The severi...

Full description

Bibliographic Details
Main Authors: Christian Czech, Wakana Tang, Teodorica Bugawan, Calvin Mano, Carsten Horn, Victor Alejandro Iglesias, Stefanie Fröhner, Phillip G Zaworski, Sergey Paushkin, Karen Chen, Thomas Kremer
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4607439?pdf=render
_version_ 1818019236431265792
author Christian Czech
Wakana Tang
Teodorica Bugawan
Calvin Mano
Carsten Horn
Victor Alejandro Iglesias
Stefanie Fröhner
Phillip G Zaworski
Sergey Paushkin
Karen Chen
Thomas Kremer
author_facet Christian Czech
Wakana Tang
Teodorica Bugawan
Calvin Mano
Carsten Horn
Victor Alejandro Iglesias
Stefanie Fröhner
Phillip G Zaworski
Sergey Paushkin
Karen Chen
Thomas Kremer
author_sort Christian Czech
collection DOAJ
description Spinal muscular atrophy is caused by a functional deletion of SMN1 on Chromosome 5, which leads to a progressive loss of motor function in affected patients. SMA patients have at least one copy of a similar gene, SMN2, which produces functional SMN protein, although in reduced quantities. The severity of SMA is variable, partially due to differences in SMN2 copy numbers. Here, we report the results of a biomarker study characterizing SMA patients of varying disease severity. SMN copy number, mRNA and Protein levels in whole blood of patients were measured and compared against a cohort of healthy controls. The results show differential regulation of expression of SMN2 in peripheral blood between patients and healthy subjects.
first_indexed 2024-04-14T07:50:16Z
format Article
id doaj.art-53d4a02249404fa68e098254b9bca7fb
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-14T07:50:16Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-53d4a02249404fa68e098254b9bca7fb2022-12-22T02:05:13ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011010e013995010.1371/journal.pone.0139950Biomarker for Spinal Muscular Atrophy: Expression of SMN in Peripheral Blood of SMA Patients and Healthy Controls.Christian CzechWakana TangTeodorica BugawanCalvin ManoCarsten HornVictor Alejandro IglesiasStefanie FröhnerPhillip G ZaworskiSergey PaushkinKaren ChenThomas KremerSpinal muscular atrophy is caused by a functional deletion of SMN1 on Chromosome 5, which leads to a progressive loss of motor function in affected patients. SMA patients have at least one copy of a similar gene, SMN2, which produces functional SMN protein, although in reduced quantities. The severity of SMA is variable, partially due to differences in SMN2 copy numbers. Here, we report the results of a biomarker study characterizing SMA patients of varying disease severity. SMN copy number, mRNA and Protein levels in whole blood of patients were measured and compared against a cohort of healthy controls. The results show differential regulation of expression of SMN2 in peripheral blood between patients and healthy subjects.http://europepmc.org/articles/PMC4607439?pdf=render
spellingShingle Christian Czech
Wakana Tang
Teodorica Bugawan
Calvin Mano
Carsten Horn
Victor Alejandro Iglesias
Stefanie Fröhner
Phillip G Zaworski
Sergey Paushkin
Karen Chen
Thomas Kremer
Biomarker for Spinal Muscular Atrophy: Expression of SMN in Peripheral Blood of SMA Patients and Healthy Controls.
PLoS ONE
title Biomarker for Spinal Muscular Atrophy: Expression of SMN in Peripheral Blood of SMA Patients and Healthy Controls.
title_full Biomarker for Spinal Muscular Atrophy: Expression of SMN in Peripheral Blood of SMA Patients and Healthy Controls.
title_fullStr Biomarker for Spinal Muscular Atrophy: Expression of SMN in Peripheral Blood of SMA Patients and Healthy Controls.
title_full_unstemmed Biomarker for Spinal Muscular Atrophy: Expression of SMN in Peripheral Blood of SMA Patients and Healthy Controls.
title_short Biomarker for Spinal Muscular Atrophy: Expression of SMN in Peripheral Blood of SMA Patients and Healthy Controls.
title_sort biomarker for spinal muscular atrophy expression of smn in peripheral blood of sma patients and healthy controls
url http://europepmc.org/articles/PMC4607439?pdf=render
work_keys_str_mv AT christianczech biomarkerforspinalmuscularatrophyexpressionofsmninperipheralbloodofsmapatientsandhealthycontrols
AT wakanatang biomarkerforspinalmuscularatrophyexpressionofsmninperipheralbloodofsmapatientsandhealthycontrols
AT teodoricabugawan biomarkerforspinalmuscularatrophyexpressionofsmninperipheralbloodofsmapatientsandhealthycontrols
AT calvinmano biomarkerforspinalmuscularatrophyexpressionofsmninperipheralbloodofsmapatientsandhealthycontrols
AT carstenhorn biomarkerforspinalmuscularatrophyexpressionofsmninperipheralbloodofsmapatientsandhealthycontrols
AT victoralejandroiglesias biomarkerforspinalmuscularatrophyexpressionofsmninperipheralbloodofsmapatientsandhealthycontrols
AT stefaniefrohner biomarkerforspinalmuscularatrophyexpressionofsmninperipheralbloodofsmapatientsandhealthycontrols
AT phillipgzaworski biomarkerforspinalmuscularatrophyexpressionofsmninperipheralbloodofsmapatientsandhealthycontrols
AT sergeypaushkin biomarkerforspinalmuscularatrophyexpressionofsmninperipheralbloodofsmapatientsandhealthycontrols
AT karenchen biomarkerforspinalmuscularatrophyexpressionofsmninperipheralbloodofsmapatientsandhealthycontrols
AT thomaskremer biomarkerforspinalmuscularatrophyexpressionofsmninperipheralbloodofsmapatientsandhealthycontrols